The ubiquitination of cell cycle regulatory proteins by the anaphase-promoting complex/cyclosome (APC/C) controls sister chromatid segregation, cytokinesis and the establishment of the G1 phase of the cell cycle. The APC/C is an unusually large multimeric cullin-RING ligase. Its activity is strictly dependent on regulatory coactivator subunits that promote APC/Csubstrate interactions and stimulate its catalytic reaction. Because the structures of many APC/C subunits and their organization within the assembly are unknown, the molecular basis for these processes is poorly understood. Here, from a cryo-electron microscopy reconstruction of a human APC/C-coactivator-substrate complex at 7.4 Å resolution, we have determined the complete secondary structural architecture of the complex. With this information we identified protein folds for structurally uncharacterized subunits, and the definitive location of all 20 APC/C subunits within the 1.2 MDa assembly. Comparison with apo APC/C shows that the coactivator promotes a profound allosteric transition involving displacement of the cullin-RING catalytic subunits relative to the degron-recognition module of coactivator and APC10. This transition is accompanied by increased flexibility of the cullin-RING subunits and enhanced affinity for UBCH10-ubiquitin, changes which may contribute to coactivator-mediated stimulation of APC/C E3 ligase activity.
1
. The anaphasepromoting complex/cyclosome (APC/C) is an E3 cullin-RING ligase that mediates ubiquitin-dependent proteolysis of specific regulatory proteins to control chromosome segregation in mitosis, the events of cytokinesis and mitotic exit, maintenance of G1, and the initiation of DNA replication 2, 3 . Through its cullin-RING catalytic module, the APC/C is related to the Skp1-Cullin-F-box protein (SCF) E3 ligases responsible for controlling S and G2 progression. However, compared to other RING ligases, the APC/C is unusually large. The reasons for its complexity likely arise from its role in orchestrating multiple cell cycle processes, its regulation by protein phosphorylation, and as the ultimate effector of the spindle assembly checkpoint 4 . The activity of the APC/C is tightly controlled by structurally related coactivator subunits (either CDC20 or CDH1). Their interaction with the APC/C is reciprocally regulated by CDK-dependent phosphorylation of core APC/C and coactivator subunits, resulting in a switch of CDC20 and CDH1 in late mitosis and change of substrate specificity. Coactivators recruit substrates to the APC/C by recognizing conserved destruction motifs or degrons-the D box 5 and KEN box 6 . In addition to their substrate recruitment roles, coactivators stimulate the E3 ligase activity of the APC/C through an unknown mechanism 7 . The activated APC/C-coactivator complex is an assembly of 15 different proteins in vertebrates (,1.2 MDa), of which only four have roles in catalysis (APC2 and APC11) and substrate recognition (APC10 and coactivator) (Extended Data Table 1a ). Other large APC/C subunits function as molecular scaffolds to coordinate the juxtaposition of the catalytic and degron-recognition modules, although more direct roles in substrate and/or E2-ubiquitin interactions are also possible. Remarkably, all scaffolding subunits incorporate multiple repeat motifs. These include five TPR (tetratricopeptide repeat) proteins, the PC (proteasome/cyclosome) domain of APC1, and putative WD40 domain in APC4.
Reconstitution of recombinant APC/C facilitated its structural and biochemical analysis, providing definition of subunit stoichiometry and the location of many APC/C subunits within the electron microscopyderived molecular envelope [8] [9] [10] . However, the structures and locations of numerous APC/C subunits remained unknown, and there were uncertainties regarding the location of its catalytic centre. To address these questions we determined a sub-nanometre resolution electron microscopy reconstruction of human APC/C as a ternary complex with the coactivator CDH1 and a high affinity substrate HSL1 (refs 11, 12) (APC/C-CDH1-HSL1). From this reconstruction we derived the complete secondary structure of the APC/C, allowing us to define the architectures and correctly assign positions of all APC/C subunits. In addition, we found that coactivator enhances APC/C affinity for UBCH10-ubiquitin, explaining at least in part how the coactivator stimulates APC/C ubiquitination activity. Comparison of ternary and apo APC/C structures defines the basis of the coactivator-mediated allosteric transition and provides insights into the mechanisms underlying this increased affinity for UBCH10-ubiquitin.
APC/C architecture
We determined a three dimensional reconstruction of the human APC/ C-CDH1-HSL1 ternary complex to a nominal resolution of 7.4 Å (Fig. 1 , Extended Data Figs 1 and 2 and Extended Data Table 1b ). The resultant map is of sufficient quality to visualize a-helices as discrete rods and b-sheets as planar densities. Figure 1 shows three views of the APC/C with its molecular envelope colour-coded according to subunit assignments, together with the underlying secondary structure elements and architecture of individual APC/C subunits (Supplementary Video 1). Our higher resolution map indicates revised positions for APC1 and APC2. These subunits were previously assigned by means of antibody labelling 13, 14 which guided docking of APC2 into a lower resolution electron microscopy map of budding yeast APC/C 15 . The APC/C adopts a triangular shape delineated by a lattice-like shell 8, [13] [14] [15] [16] [17] ( Fig. 1) . The back and top of the complex is formed from the bowl-shaped *These authors contributed equally to this work.
TPR lobe-an assembly of the four canonical TPR proteins and their accessory subunits (Extended Data Table 1a ). The base of the APC/C comprises the platform subunits of APC4 and APC5, together with two domains of APC1. The carboxy-terminal PC domain of APC1 (APC1   PC   ) extends from the platform to contact the TPR lobe (Fig. 1b) . The degronrecognition module of APC10 and CDH1 is located at the top of the cavity with APC10 interacting extensively with APC1 PC . The catalytic subunits APC2 (cullin) and APC11 (RING) of APC/C are positioned at the periphery of the platform such that the C-terminal domain of APC2 (APC2   CTD   ) and associated APC11 are at the front of the cavity below APC10 and CDH1 (Fig. 1a) .
The TPR lobe is a quasi-symmetric array
The four evolutionarily related TPR proteins of the TPR lobe self-associate to form similar V-shaped homodimers ( Fig. 2a-d) . Each subunit comprises an a-helical solenoid with two turns of TPR helix [18] [19] [20] . With the amino-terminal TPR helix forming the homodimer interface, the Cterminal TPR helix creates a protein-binding groove. APC6 binds its accessory subunit APC12 through this groove (Fig. 2a ) 18, 19 , whereas the APC3 and APC8 homodimers utilize one of their dyad-related C-terminal grooves to engage CDH1 (described below). APC10 contacts the TPR helical groove of the opposite subunit of the APC3 homodimer. Relative to the full-length Schizosaccharomyces pombe crystal structure 19 , APC6 differs slightly in the context of the APC/C (Extended Data Fig. 3a and b and Supplementary Video 1).
TPR homodimers stack in parallel to generate a left-handed suprahelix featuring quasi-twofold symmetry (Figs 1, 2e and Supplementary Video 1) 20 . An ordered assembly of the TPR lobe is partly determined by the TPR accessory subunits APC13 and APC16, whose extended conformations span multiple TPR subunits (Fig. 2e) . APC16 was identified as a long rod-like density and modelled as a 40-residue a-helix. It lies along the shallow grooves created by a-helices of TPR subunits APC3 and APC7 (interfaces i to iii) ( Fig. 1 and Extended Data Fig. 3c ). The location of APC16 agrees with its mapping to the upper region of the TPR lobe 21 , and its co-purification with an APC3-APC7 sub-complex (data not shown). APC13 interacts with APC3, APC6 and APC8 (interfaces iv to vii) ( Fig. 1 and Fig. 2e and Extended Data Fig. 3c ), consistent with electron microscopy analysis of an APC13-green fluorescent protein fusion that positioned APC13 close to the APC6-APC3 interface 8 .
Architectures of APC1, APC4 and APC5
APC4 and APC5 were assigned to the platform through antibody labelling 14 , a negative stain electron microscopy analysis of an APC4-APC5 subcomplex 8 , and assignment of toroidal density to the putative WD40 domain of APC4 (ref. 14) (Supplementary Video 1) . Analysis of the platform in the APC/C-CDH1-HSL1 map reveals that the toroidal density comprises a WD40 domain (APC4 WD40 ) attached to a long helical bundle domain (APC4 HBD ) ( Fig. 3a and Extended Data Fig. 3d ). This proposed architecture of APC4 is consistent with two-dimensional class views of an APC4-mFab complex derived using negatively stained electron micrographs (Extended Data Fig. 4 
, is located adjacent to APC2, APC5 and APC8 (Fig. 1a, b Fig. 3e ). Its eleven PC repeats assemble into a closed toroidal structure of two concentric rings of a-helices encircling two axial a-helices. Electron microscopy density corresponding to these 24 co-linear a-helices is resolved adjacent to APC10. The rodshaped density immediately beneath APC1 PC , connecting it to the platform, resembles an a-helical solenoid (Figs 1b and 3c) , and corresponds to the predicted ,300-residue mid-helical domain of APC1 (APC1 MHD ). At the interface of the mid-helical and PC domains, a small b-sandwich structure (Fig. 3c ) was assigned to the predicted b-sheet that immediately follows APC1 PC . A third toroidal-shaped density, located adjacent to APC1 MHD , was assigned as the N-terminal WD40 domain of APC1 (APC1 WD40 ) ( Fig. 3c and Extended Data Fig. 3f) , consistent with the b-strand prediction for the N terminus of APC1. APC1 WD40 tucks into the helical groove of APC5 TPR (Fig. 1c) , and forms an edge-on contact with the C-terminal TPR helix of APC8 (Fig. 1b) .
APC15 was identified from difference density from a reconstitution of the APC/C with APC15 deleted (APC/C DAPC15 ) (Figs 1c, 3d and Extended Data Figs 1, 2 ). This revealed APC15 as the helical density bridging APC8 and APC5 (Fig. 3e) , connected to an extended structure that inserts into the inner groove of the APC5 TPR superhelix (Fig. 3d, e ). An interaction of APC15 with APC8 and platform subunits is in agreement with biochemical and structural evidence 8, 9, 23 .
The catalytic module is flexible
For APC2, only a-helices of the N-terminal cullin repeats are clearly identified in the electron microscopy map (Fig. 1a and Fig. 3f ). Density for APC2
CTD and APC11 is weak and fragmented. In an unsharpened map calculated to reveal low-resolution features, the APC2 CTD -APC11 module is recovered as a horn-like density (Fig. 3g ), similar to a feature described in the 25 Å resolution cryo-electron microscopy map of apo S. pombe APC/C 16 . Three dimensional classification of the APC/C-CDH1-HSL1 electron microscopy data indicated structural variability of this density (Extended Data Fig. 5 ), consistent with the notion that the APC2 CTD -APC11 module is flexible. We used a well-defined three dimensional class to dock APC2 CTD -APC11, although in this density the APC11 RING domain cannot be located precisely (Fig. 3g) . Because of the flexibility of APC2 CTD , we cannot exclude the possibility that APC11 RING is displaced from APC2 CTD , similar to the Rbx1 RING domain of the activated SCF 24, 25 .
Degron recognition by CDH1 and APC10
CDH1 and APC10 are in close proximity within the inner cavity adjacent to the APC3 homodimer 15, 17 (Fig. 4a, d ).
Other segments of HSL1 are unstructured and not defined in the electron microscopy map. Crystallographic studies indicated that the D boxrecognition site on coactivator is a channel on the edge of the WD40 domain that engages the D box motif RxxLxx(V/I/L) (residues P1 to P7), but not conserved polar residues P8 to P10 (ref. 26 ). In the APC/ C-CDH1-HSL1 electron microscopy map, we observe tubular density that extends from the D box at the coactivator D box-binding site and connects with APC10. Modelling this density as P8 to P10 shows that these residues interact with a conserved polar surface on APC10 (Fig. 4d) . Disruption of a loop that comprises this site (the 140s loop) impairs D box-dependent substrate recognition 32 . Ala substitutions of two hydrophilic residues (Ser 88 and Asn 147) in close proximity to P8 to P10 of the D box (Fig. 4d) attenuates APC/C CDH1 ubiquitination activity, as does mutation of D box residues P8 to P10 (Extended Data Fig. 6 ). Thus, the D box is a bipartite degron comprising a coactivator-interacting N-terminal (RxxLxx(V/I/L)) motif, and a hydrophilic C-terminal APC10-binding segment (Fig. 4e ).
CDH1 promotes an allosteric transition
We could also visualize components of the N-terminal segment of CDH1 (CDH1 NTD ). This forms a four a-helix bundle that packs co-linearly with the a-helices of APC1 PC and also contacts APC6 (Fig. 4f , g and Extended Data Fig. 3g ). In addition, an extended segment of CDH1 NTD (L1) binds to the inner groove of the APC8B TPR helix, interacting with three TPR motifs that are structurally related to the IR tail-binding site of APC3 (Fig. 4c) , and which contribute to coactivator binding 12, 35 . The N terminus of coactivator stimulates APC/C ubiquitin ligase activity, independent of degron recognition 7 . To understand coactivatormediated APC/C activation in the context of our complete subunit assignment, we determined three dimensional reconstructions of apo APC/C (Extended Data Figs 1 and 2 ). The most prominent structural difference between apo and ternary complexes involves a displacement of the platform subunits (Fig. 5a, b ), similar to those described at lower resolution for Xenopus and human APC/C 13, 14 . Moreover, in the apo state, electron microscopy density for APC2
CTD is more clearly defined (Fig. 5a, c) NTD with APC1 PC and APC8B. In the apo state, the C-terminal TPR helix of APC8B is well ordered and interacts with APC1 PC (Fig. 4f ). In the ternary complex, CDH1 NTD disrupts this interaction by binding to a site on APC1 PC that overlaps the site in contact with APC8B. This wedges APC1 PC and APC8B apart and disorders TPR motifs 13 and 14 of APC8B (Fig. 4f) . A concomitant downwards-displacement of APC8B tilts the platform to translate the APC2 CTD -APC11 module upwards (Fig. 5d, e) . Coactivator-induced displacement and flexibility of the APC2 CTD -APC11 module has implications for understanding how the coactivator NTD stimulates APC/C ubiquitin ligase activity 7 . Increased catalytic activity could result from the flexibility of the APC2 CTD -APC11 module which, combined with its different location relative to the substraterecognition module, may provide enhanced substrate (and ubiquitin polymer) access to the APC/C-bound E2-ubiquitin conjugate. Other possibilities include (1) enhancing the affinity of the APC/C for the E2-ubiquitin conjugate, (2) promoting the closed more reactive configuration of the E2-donor ubiquitin conjugate to stimulate efficient ubiquitin attachment to the target lysine [36] [37] [38] [39] [40] , or (3) inducing an allosteric transition of the E2 (ref. 41).
To assess the effects of CDH1 on the affinity of APC/C for its cognate E2s we used surface plasmon resonance (SPR). Ternary APC/C bound UBCH10 with a K D of 0.2 mM, an affinity some threefold higher than apo APC/C (Extended Data Fig. 9 ). Interestingly, coactivator promoted a more pronounced sevenfold increase in APC/C's affinity for UBCH10-Ub because ubiquitin conjugation of UBCH10 reduced its affinity for apo APC/C nearly threefold, whereas binding to ternary APC/C was only slightly affected (Extended Data Fig. 9 ). In contrast to UBCH10, ternary and apo APC/C had similar affinities for UBE2S (K D 0.2 and 0.3 mM) (Extended Data Fig. 9 ), showing that coactivator-mediated APC/C activation does not enhance UBE2S affinity, and consistent with the idea that UBCH10 and UBE2S bind to distinct sites on the complex 40, 42 . The C-terminal extension of UBE2S is required for synthesis of poly-ubiquitin chains on APC/C substrates [42] [43] [44] . Deleting this C terminus to yield the UBC domain alone (UBE2S-DC) abolished UBE2S binding to the core APC/C 44 , a finding we confirmed for both apo and holo APC/C using SPR (Extended Data Fig. 9 ). The APC2 CTD -APC11 catalytic module had a low affinity for UBCH10 and did not interact with either UBCH10-Ub or UBE2S (Extended Data Fig. 9 ), indicating that high-affinity APC/C interactions with both UBCH10 and UBE2S depend on subunits other than APC2 CTD -APC11. That ubiquitin modification of UBCH10 interferes with its binding to apo APC/C suggests that the energetically-favoured conformations of the UBCH10-Ub conjugate, including the catalytically-efficient closed conformation [36] [37] [38] [39] [40] , are sterically hindered from binding apo APC/C. Thus, in addition to an increased affinity for UBCH10-Ub, a coactivatordependent conformational change that allows association of UBCH10-Ub in the closed conformation, with enhanced intrinsic catalytic activity, could also contribute to stimulation of the E3 ligase activity of APC/C. It is therefore likely that, reminiscent of how Nedd8 conjugation stimulates the SCF 45 , multiple mechanisms underlie coactivator-dependent stimulation of the APC/C, and potentially only UBCH10-responsible for initiating substrate ubiquitination 42, 43, 46 -is subject to coactivatormediated regulation.
In conclusion, comparison of our APC/C-CDH1-HSL1 ternary structure with the electron microscopy reconstructions of APC/C MCC (ref. 14) and APC/C-CDH1-EMI1 (ref. 47), determined at lower resolutions, shows that the presence of coactivator in all three complexes is associated with the same activated conformation of the platform subunits (Extended Data Fig. 8a, b) . From this analysis it is clear that the MCC makes direct contact with the APC2 CTD -APC11 module, as does the Table 1a ). The symmetry of TPR homodimers, coupled to the evolution of paralogues, may have resulted in the acquisition of replicated functions. For example, the IR tails of coactivator and APC10, and NTD of coactivator bind to equivalent sites on three TPR subunits (Fig. 4b, c) . Our model of the APC/C provides insights into the assembly of other large multimeric complexes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
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METHODS
Expression and purification of recombinant human APC/C. Recombinant wild type apo human APC/C and APC/C-CDH1-HSL1 ternary complexes were expressed and purified as described previously 10, 20 . We used residues 667 to 872 of HSL1, a high affinity APC/C CDH1 substrate 11, 12 . Apo APC/C with APC15 deleted (APC/C , APC/C-APC10(S88A/N147A)) were cloned into the Multibac system 48, 49 , essentially as described previously 10 . Electron microscopy. Freshly purified recombinant human APC/C in four states (APC/C-CDH1-HSL1 ternary complex, apo APC/C, APC/C DRING , and APC/ C DAPC15 ) were first visualized by negative stain electron microscopy to check homogeneity. Complexes were then diluted to ,200 mg ml 21 and aliquots of 2 ml were applied to Quantifoil R1.2/1.3 grids coated with a second layer of home-made thin carbon film, glow discharged with the Easiglow discharge unit (Pelco) for 30 s before use. The grids were then blotted for 5 s at room temperature and plunged into liquid ethane using an FEI Vitrobot. Frozen grids were stored in liquid nitrogen. The grids were loaded into a Gatan 626 cryo-holder and transferred to an FEI Tecnai TF20 electron microscope at an accelerating voltage of 200 keV and maintained at approximately 2176 uC. The microscope was operated in low-dose mode at a nominal magnification of 380,000 (,25 e 2 Å
22
). Images were recorded using a Tietz F415 (4k 3 4k) CCD camera with a defocus range of ,1.5 mm and ,4 mm and adjacent boxes of 2 3 2 pixels were averaged, resulting in a calibrated sampling of 2.36 Å pixel
21
. The images were taken manually and only those with a power spectrum showing Thon rings clearly extending beyond 10 Å were selected for further analysis. Image processing. Particles were selected automatically using the EMAN 50 program batchboxer and manually screened with e2boxer.py in EMAN2 (ref. 51) . Contrast transfer function parameters were calculated with CTFFING3 (ref. 52 ). The coordinates of particles (.box) and the CTFFIND3 log files were imported to RELION 53 to extract the particles, perform two dimensional and three dimensional classifications and three dimensional auto refinement. The negative stain model of the human APC/C-CDH1-HSL1 ternary complex 20 low-pass filtered to 60 Å was used as an initial model for refinements of APC/C-CDH1-HSL1 ternary complex and wild type apo state. The resultant map of wild type apo was lowpass filtered to 60 Å and used as an initial model for refinements of APC/C DRING and APC/C DAPC15 states. A summary of particles used for refinements is listed in Extended Data Table 1b .
All three dimensional refinements used gold-standard Fourier shell correlation (FSC) calculations to avoid overfitting and reported resolutions are based on the FSC 5 0.143 criterion 54, 55 . Final FSC curves were calculated using a soft spherical mask (with a 5-pixel fall-off) of the two independent reconstructions. To visualize high-resolution details, all density maps were sharpened by applying negative B-factors, estimated using automated procedures (21, 200 Å   2   ) 54 . Three dimensional classification in RELION was used to examine the heterogeneity of APC/C-CDH1-HSL1 ternary complex, which showed ,60% ternary complex and 40% apo state APC/C. The same approach was also used for classification of the final reconstructions to analyse the flexible parts of the APC2 CTD -APC11 module. For three dimensional classification, the three dimensional map refined using all particles was used as reference and local angular searches within 15u were executed. Three dimensional classifications were run for 25 iterations with the following settings: class number 5 10, angular sampling 5 7.5u, and regularization parameter T 5 4. Modelling of APC/C subunits. Modelling of the structures of APC/C subunits combined several approaches. Basically, these can be divided into three categories. (1) Use of available crystal structures of APC/C subunits or their homologous proteins to generate atomic models. This was used for crystal structures of human APC10 (residues 2-162, PDB code: 1JHJ) 27 and N-terminal seven helices of APC7 (residues 21-166, PDB code: 3FFL) 56 , S. pombe Cut9-Hcn26 complex (APC6-APC12 homologue, PDB code: 1XPI) 19 , N-terminal dimerization domains of E. cuniculi Cdc27 (APC3 homologue, PDB code: 3KAE) 57 and S. pombe Cut23 (APC8 homologue, PDB code: 3ZN3) 20 , and CDH1-D-KEN (PDB code: 4BH6) 26 . For the C-terminal TPR helices of APC3, APC8 and APC7, the crystal structure of the C-terminal TPR helix of S. pombe Cut9 was used as a model. The crystal structure of S. pombe Cut9 was also used to build a model of the 13 TPR motifs of APC5. For APC2-APC11, the crystal structure of Cul1 (PDB code: 1U6G) 58 was used as model. For APC1-PC repeats, structure was predicted with I-Tassar 59 using PC repeats structure of Rpn2 (PDB code: 4ADY) 22 as a reference. (2) Several domain structures could be recognized directly from our sub-nanometre resolution maps. For example, the WD40 domain of CDH1 was used for modelling of APC4 WD40 and APC1 WD40 like domains, as seven blades could be seen directly from the electron microscopy map. The APC4-helix-bundle (APC4 HBD ) was modelled with crystal structure of the four helix-bundle SNARE complex (PDB code: 1SFC) 60 . All these models were rebuilt manually followed by flexible fitting with MDFF. (3) Small subunits or domains without homologue protein structures were modelled by ab initio prediction using Phyre2 (ref. 61) Fitting atomic coordinates to cryo-electron microscopy maps. Rigid-body fitting was performed by 'fit in map' program in Chimera 62 . This was applied to APC10 and the CDH1 WD40 domain, crystal structure of which fitted well into the cryo electron microscopy map without flexible fitting. Flexible fitting for other subunits was performed using MDFF (Molecular dynamics flexible fitting) 63 based on rigid-body fitting. The initial system was prepared for MDFF using Visual Molecular Dynamics (VMD) 64 and run in the Not Another Molecular Dynamics (NAMD) program 65 for 200 ps of simulation time. All MDFF runs were performed with default parameters, using implicit solvent and temperature annealing. For the IR tails of CDH1 and APC10, the models were refined with COOT ) substrates were expressed and purified. Human ubiquitin with an N-terminal His 6 tag was purified in Escherichia coli. Human UBA1 was expressed and purified using the pGEX6.1 system. Human UBCH10 was expressed and purified using the pET28 expression system. Human CDH1 with an N-terminal His 6 -haemagglutinin dual tag was expressed and purified from insect cells. UBCH10 ubiquitination assays were performed as previously described method with minor modification 10 . Immediately after preparation on ice, APC/C and substrate were added to an ubiquitination mix (containing all components except APC/C and substrate) to 10 ml reaction mix (40 mM Tris (pH 7.5), 10 mM MgCl 2 , 0.6 mM DTT, 5 mM ATP, 150 nM UBA1 (E1), 300 nM UBCH10 (E2), 2 mM CDH1, 70mM His 6 -ubiquitin, 0.25 mg ml 21 BSA, 60 nM APC/C, 2 mM substrate). Reaction mixtures were incubated at room temperature (22 uC) and terminated by addition of SDS/PAGE loading buffer at 0, 10, 20 and 30 min. Reactions were then analysed by SDS/PAGE (8-12% gradient gels) followed by western blotting with an antibody against His 6 -ubiquitin. UBE2S assays were performed similar to UBCH10 except for use of the modified substrate gluthatione-S-transferase-HSL1(0K)-His 6 -ubiquitin (data not shown). APC4-mFab generation and purification. Human APC4 protein was purified as a by-product of APC/C expression and purification. The purified APC4 protein was buffer changed into PBS at 1 mg ml 21 . A number of monoclonal antibodies were prepared using standard procedures (OxFabs). ELISA assays identified three mABs, 152A, 25A and 291A that recognize native HsAPC4, and 152A can also recognize denatured APC4. The antibodies were purified using Protein A Sepharose (GE Healthcare Life Sciences). mFabs were generated and purified using the Fab preparation Kit (Pierce). The APC4-mFab complex for negative stain electron microscopy studies (prepared by mixing APC4 with mFab 152A at a 2:1 ratio) was further separated by Superpose 6 column (GE Healthcare Life Sciences). Surface plasmon resonance experiments. Human UBCH10 (Ube2C), DN-UBCH10 (residues 4-32 deleted), UBE2S and UBE2S-DC (residues 1 to 160) fused to Avi-Tev-His 6 tags were prepared and expressed in E. coli using the pET28 expression system. UBCH10 was fused to a C-terminal Avi-Tev-His 6 tag (GSA GLNDIFEAQKIEWHE ENLYFQS HHHHHH) (Avi tag underlined) whereas an N-terminal (HHHHHH ENLYFQS GSAGLNDIFEAQKIEWHE) tag was fused to UBE2S. E2s were purified using Ni-NTA chromatography, TEV cleavage and gel filtration and biotinylated in vitro using BirA ligase, (expressed from a pET21a vector (Addgene) and purified as described 67 in buffer: 50 mM bicine, pH 8.3, 10 mM ATP, 10 mM Mg acetate, 250 mM D-biotin for 16 h at 22 uC at a ratio of 10:1 E2:BirA. The biotinylated proteins were further purified by size exclusion chromatography. To prepare UBCH10-Ub, the catalytic Cys 114 was mutated to Lys and conjugated with ubiquitin following a published procedure as described for UbcH5 (ref. 37) . Specifically, UBCH10(C114K)-Avi (200 mM) was incubated with His 6 -tagged ubiquitin (200 mM) at 35 uC for 24 h in a buffer containing 1 mM UBA1, 3 mM ATP, 5 mM MgCl 2 , 0.8 mM TCEP, 150 mM NaCl, 50 mM Tris pH 9.5. After addition of 20 mM imidazole, the reaction was applied to a Ni-NTA column pre-equilibrated with Ni-NTA binding/washing RESEARCH ARTICLE buffer (50 mM Tris pH 8.0, 150 mM NaCl, 20 mM imidazole). The free UBCH10(C114K) Avi flowed through, whereas the conjugate and free ubiquitin were eluted with 100 mM imidazole in Ni-NTA binding/washing buffer. The UBCH10-Ub conjugate was separated from free ubiquitin by S75 size exclusion column. Biotinylated UBCH10-Ub was prepared as for UBCH10.
APC2 (residues 549-822)-APC11 (APC2 CTD -APC11 catalytic module) (baculovirus prepared by W. Chao and J. He) was expressed using the insect cell baculovirus system and purified using Strep-Tactin chromatography, TEV cleavage and gel filtration chromatography. Ternary and apo APC/C were purified as above with TEV cleavage to remove the StrepII tag.
SPR was performed using a Biacore T200 using streptavidin-coated sensor chips (SA chips GE Healthcare). Both reference control SA and analyte SA chips were equilibrated in SPR buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 0.02% Tween 20, 0.5 mg ml 21 BSA, 1 mM DTT) at 20 uC. E2s were immobilised onto the analyte SA chips to reach an RU value of ,400. Analytes (APC/C and APC2 CTD -APC11) were buffer exchanged into SPR buffer by means of Zebra spin desalting columns (Pierce) and then centrifuged at 30,000g for 30 min to remove aggregates. SPR runs were performed with analytes injected for 120 s followed by a 600 s dissociation in 1:2 dilution series with initial concentrations of APC/C at 700 to 900 nM and that of APC2 CTD -APC11 at ,45 mM. Data were fitted using a single site interaction model using KaleidaGraph (Synergy Software) and Prism (GraphPad Software Inc.) to determine k on , k off and K D (kin) , and by measuring the equilibrium response (R eq ), where appropriate, near the maximum response to determine K D (eq) . Biotinylation of UBCH10 and UBE2S had no effect on APC/ C CDH1 E3 ligase activity, determined at concentrations of 0.3 mM UBCH10 and UBE2S (that is, close to their K D values, data not shown). DN-UBCH10 had similar relative affinities for ternary and apo APC/C (data not shown). The activity of DN-UBCH10 relative to untagged wild type UBCH10 in an APC/C CDH1 ubiquitination assay was similar to UBCH10, except for the production of higher molecular weight ubiquitinated HSL1 species (data not shown). A similar increase in higher molecular weight ubiquitinated products (cyclin A and securin) was reported in ref. 68 . In addition to Avi-Biotin-UBE2S-DC as a negative control, a biotinylated peptide corresponding to the biotinylated tag fused to UBCH10 (GSAGLNDIFEAQ(KBiotin)IEWHEENLYFQ) (Designer BioScience, Cambridge) was immobilized to the analyte SA sensor chip at a similar concentration to the E2s. No interaction with either apo or ternary APC/C was detected (data not shown). ARTICLE RESEARCH
